MA52348A - Composés hétéroaromatiques ayant une activité contre vrs - Google Patents

Composés hétéroaromatiques ayant une activité contre vrs

Info

Publication number
MA52348A
MA52348A MA052348A MA52348A MA52348A MA 52348 A MA52348 A MA 52348A MA 052348 A MA052348 A MA 052348A MA 52348 A MA52348 A MA 52348A MA 52348 A MA52348 A MA 52348A
Authority
MA
Morocco
Prior art keywords
activity against
heteroaromatic compounds
against rsv
rsv
heteroaromatic
Prior art date
Application number
MA052348A
Other languages
English (en)
Inventor
Sovy Chao
Jérôme Émile Georges Guillemont
David Francis Alain Lançois
Antoine Benjamin Michaut
Sabrina Dany France Quatrevaux
Pierre Jean-Marie Bernard Raboisson
Peter Rigaux
Dirk André Emmy Roymans
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MA52348A publication Critical patent/MA52348A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA052348A 2018-04-23 2019-04-19 Composés hétéroaromatiques ayant une activité contre vrs MA52348A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18168671 2018-04-23

Publications (1)

Publication Number Publication Date
MA52348A true MA52348A (fr) 2021-03-03

Family

ID=62046706

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052348A MA52348A (fr) 2018-04-23 2019-04-19 Composés hétéroaromatiques ayant une activité contre vrs

Country Status (13)

Country Link
US (1) US11708369B2 (fr)
EP (1) EP3784667B1 (fr)
JP (1) JP2021522222A (fr)
KR (1) KR20210005569A (fr)
CN (1) CN112004815A (fr)
AU (1) AU2019260109B2 (fr)
CA (1) CA3095277A1 (fr)
EA (1) EA202092439A1 (fr)
ES (1) ES2957316T3 (fr)
MA (1) MA52348A (fr)
MX (1) MX2020011200A (fr)
SG (1) SG11202010323QA (fr)
WO (1) WO2019206828A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202006141RA (en) 2018-01-31 2020-07-29 Janssen Sciences Ireland Unlimited Co Cycloalkyl substituted pyrazolopyrimidines having activity against rsv
US11708369B2 (en) * 2018-04-23 2023-07-25 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against RSV
JP2023527792A (ja) 2020-05-27 2023-06-30 アキシャル セラピューティクス，インク． Ｔｌｒ２調節剤化合物、医薬組成物、及びそれらの使用
CA3200111C (fr) 2020-10-28 2025-02-18 Shionogi & Co., Ltd. Dérivé d’amide ayant une activité antivirale

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019483A1 (fr) 1994-12-22 1996-06-27 Biochem Pharma Inc. Inhibiteurs de la thrombine bicyclique a faible poids moleculaire
CA2225255A1 (fr) 1995-06-29 1997-01-16 Merck & Co., Inc. Combinaisons d'inhibiteurs de farnesyl-proteine transferase
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
US5972966A (en) 1996-12-05 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5977134A (en) 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
KR20020063837A (ko) 1999-07-19 2002-08-05 시오노기세이야쿠가부시키가이샤 아실옥시메톡시카르보닐 측쇄를 갖는 삼환 화합물
EP1113007A1 (fr) 1999-12-24 2001-07-04 Pfizer Inc. Composés de tétrahydroisoquinoline comme agonistes/antagonistes d'oestrogène
US20030073681A1 (en) 2001-08-21 2003-04-17 Hauske James R. 2-substituted piperidines that are ligands for monoamine receptors and transporters
US7662826B2 (en) 2002-04-23 2010-02-16 Shionogi & Co., Ltd. Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same
CA2499523C (fr) 2002-09-20 2011-04-19 Medisyn Technologies, Inc. Agents therapeutiques et traitements correspondants
JP2006504803A (ja) 2002-09-26 2006-02-09 ファイザー・インク ピラゾール誘導体
AU2003275632A1 (en) 2002-10-25 2004-05-13 Mitsubishi Pharma Corporation N-oxide compounds
TW200505902A (en) 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
WO2004087153A2 (fr) 2003-03-28 2004-10-14 Chiron Corporation Utilisation de petites molecules de composes pour une immunopotentialisation
FR2856596B1 (fr) 2003-06-27 2007-04-27 Bioprojet Soc Civ Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes.
US20070060595A1 (en) 2003-10-10 2007-03-15 Toshio Yoshizawa Novel fused heterocyclic compound and use thereof
US7323567B2 (en) 2003-10-30 2008-01-29 Boehringer Ingelheim (Canada) Ltd. RSV polymerase inhibitors
AR046959A1 (es) 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
NZ551468A (en) 2003-12-24 2010-05-28 Biota Scient Management Polycyclic agents for the treatment of respiratory syncytial virus infections
US8143404B2 (en) 2004-09-13 2012-03-27 Ono Pharmaceutical Co., Ltd Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
BRPI0515500A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
WO2007044085A2 (fr) 2005-05-19 2007-04-19 Xenon Pharmaceuticals Inc. Composes heteroaryle et leurs utilisations en tant qu'agents therapeutiques
AU2006260969B2 (en) 2005-06-20 2011-11-17 Janssen Sciences Ireland Uc 1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) -3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
EP1957476A1 (fr) 2005-11-23 2008-08-20 AstraZeneca AB Derives de l-alanine
CA2670083A1 (fr) 2006-11-20 2008-05-29 Alantos Pharmaceuticals Holding, Inc. Inhibiteurs de metalloprotease heterobicycliques
CA2695989A1 (fr) 2007-08-10 2009-02-19 Glaxosmithkline Llc Entites chimiques bicycliques azotees pour traiter les infections virales
US8450343B2 (en) 2007-12-06 2013-05-28 Xianhai Huang Gamma secretase modulators
CN102186479A (zh) 2008-09-10 2011-09-14 凯利普西斯公司 用于治疗疾病的组胺受体的氨基嘧啶抑制剂
AR073920A1 (es) 2008-10-23 2010-12-09 Boehringer Ingelheim Int Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion.
US20100204265A1 (en) 2009-02-09 2010-08-12 Genelabs Technologies, Inc. Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
KR20100101055A (ko) 2009-03-07 2010-09-16 주식회사 메디젠텍 세포핵에서 세포질로의 ｇｓｋ３의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 ｇｓｋ３ 이동 관련 질환의 치료 또는 예방용 약학적 조성물
AU2010229142A1 (en) 2009-03-23 2011-10-13 Merck Sharp & Dohme Corp. P2X3, receptor antagonists for treatment of pain
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
EA020031B1 (ru) 2009-06-11 2014-08-29 Эббви Бахамаз Лтд. Противовирусные соединения
PT3012258T (pt) 2010-06-24 2018-12-14 Gilead Sciences Inc Composição farmacêutica compreendendo um derivado de pirazolo[1,5-a]pirimidina como agente antiviral
JP6122868B2 (ja) 2011-12-22 2017-04-26 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン
AU2013249280B2 (en) 2012-04-17 2017-10-12 Gilead Sciences, Inc. Compounds and methods for antiviral treatment
CA2924527C (fr) 2013-09-20 2022-07-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Composes destines au traitement du cancer de la prostate
US10087151B2 (en) 2014-01-09 2018-10-02 The J. David Gladstone Institutes, A Testimentary Trust Established Under The Will Of J. David Gladstone Substituted benzoxazine and related compounds
KR101551313B1 (ko) 2014-07-28 2015-09-09 충남대학교산학협력단 신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물
WO2016071293A2 (fr) 2014-11-03 2016-05-12 Iomet Pharma Ltd Composé pharmaceutique
WO2016091774A1 (fr) 2014-12-08 2016-06-16 Janssen Sciences Ireland Uc Dérivés de pyrazolo[1,5-a]pyrimidine substitués par pipéridin, ayant une activité inhibitrice sur la réplication du virus respiratoire syncytial (rsv)
CN105777632A (zh) 2015-01-09 2016-07-20 成都贝斯凯瑞生物科技有限公司 芳环并氮杂环衍生物及其应用
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
SG11202006141RA (en) 2018-01-31 2020-07-29 Janssen Sciences Ireland Unlimited Co Cycloalkyl substituted pyrazolopyrimidines having activity against rsv
US11708369B2 (en) * 2018-04-23 2023-07-25 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against RSV
EA202191482A1 (ru) 2018-11-26 2021-12-14 Янссен Сайенсиз Айрлэнд Анлимитед Компани Другие гетероароматические соединения, обладающие активностью против rsv
EA202193223A1 (ru) 2019-05-23 2022-03-10 Янссен Сайенсиз Айрлэнд Анлимитед Компани Другие гетероароматические соединения, действующие против рсв

Also Published As

Publication number Publication date
KR20210005569A (ko) 2021-01-14
EP3784667A1 (fr) 2021-03-03
JP2021522222A (ja) 2021-08-30
ES2957316T3 (es) 2024-01-17
US11708369B2 (en) 2023-07-25
US20210094958A1 (en) 2021-04-01
CN112004815A (zh) 2020-11-27
AU2019260109B2 (en) 2023-07-13
EP3784667C0 (fr) 2023-08-16
AU2019260109A1 (en) 2020-09-17
EP3784667B1 (fr) 2023-08-16
SG11202010323QA (en) 2020-11-27
CA3095277A1 (fr) 2019-10-31
MX2020011200A (es) 2020-11-13
WO2019206828A1 (fr) 2019-10-31
EA202092439A1 (ru) 2021-03-05

Similar Documents

Publication Publication Date Title
IL279801A (en) Pesticidally active azole-amide compounds
EP3836923A4 (fr) Composés pyrrolo-dipyridine
EP3720430A4 (fr) Composés benzocarbonyle
MA52948A (fr) Composés
MA51669A (fr) Composés
EP3691623A4 (fr) Composés de benzosulfonyle
MA47131A (fr) Composés benzyl-amide phosphodiamide antiviraux
LT3829332T (lt) Aerozolį generuojantis gaminys, apimantis aerozolį generuojantį substratą
EP3737672A4 (fr) Composés benzamide
MA53003A (fr) Composés
EP3551176A4 (fr) Composés hétérocycliques antidiabétiques
EP3445750A4 (fr) Composés thérapeutiques
EP3728289A4 (fr) Composés optimisés
EP3464336A4 (fr) Composés
DK3844161T3 (da) Heteroaromatiske forbindelser som vanininhibitorer.
MA52348A (fr) Composés hétéroaromatiques ayant une activité contre vrs
MA52946A (fr) Composés
MA49621A (fr) Composés bifonctionnels
EP3778573A4 (fr) Composé présentant une activité anticancéreuse
EP4077318A4 (fr) Composés
EP3709995A4 (fr) Composés bicycliques antidiabétiques
EP3956220C0 (fr) Support d'uav
EP3713941A4 (fr) Composés de pyrazolopyridinone
EP3717483A4 (fr) Composés de pyrazolopyridinone
MA54286A (fr) Autres composés hétéroaromatiques ayant une activité contre le vrs